Figure LegendsFig 1: Immune mechanism for production of AChR antibodies in
Myasthenia Gravis (This figure is reproduced with permission from
‘frontiers in immunology’. Fichtner ML, Jiang R, Bourke A, Nowak RJ,
O’Connor KC. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes
Is Governed by Divergent Mechanisms of Immunopathology. Front Immunol.
2020;11:776. Published 2020 May 27. doi:10.3389/fimmu.2020.00776)Fig 2: Immune mechanism for production of MuSK antibodies in
Myasthenia Gravis (This figure is reproduced with permission from
‘frontiers in immunology’. Fichtner ML, Jiang R, Bourke A, Nowak RJ,
O’Connor KC. Autoimmune Pathology in Myasthenia Gravis Disease Subtypes
Is Governed by Divergent Mechanisms of Immunopathology. Front Immunol.
2020;11:776. Published 2020 May 27. doi:10.3389/fimmu.2020.00776)Fig 3: Flowchart showing the classification of
Myeloproliferative Neoplasms based on chromosomal mutations.